Company intelligence / Profile preview

STC Biologics, Inc.

Newton, Massachusetts, United Statesstcbiologics.com ↗

Ownership: Private
Employees: ~34
Development stage: Commercial

Overview

No direct clinical results as the company operates as a CDMO supporting client programs. Known for analytics-driven process development and expertise in biosimilar product development with innovative approaches to cell line selection and process optimization.

Therapeutic areas: Other
Modalities: Monoclonal antibodies (mAbs)BiosimilarsTherapeutic proteinsEnzymesOther biologic drugs
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

STC101

Phase 1

Indications: Biosimilar

Partnerships

Partners with various pharmaceutical and biotechnology companies to expedite drug development, especially in analytical/process development. Specific partners are not publicly named.

Beyond the preview

Go deeper on STC Biologics, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on STC Biologics, Inc..